shown to interact with: SH2B2 SQSTM1 KIDINS220 PTPRS MAPK8IP3/JIP3 Neurotrophin-3 TβRII DOK5 BMPRII PLCG1 Ligands Small molecules peptidomimetics based on β-turn NT-3, with the rationale of targeting the extracellular domain of the TrkC receptor have shown to be agonist of TrkC. Posterior studies, have shown that peptidomimetics with an organic backbone, and a pharmacophore based on β-turn NT-3 structure can also function as an antagonist of TrkC. References Further reading Developmental neuroscience Programmed cell death Tyrosine kinase receptors